《追求不朽》:介绍Metadicholandreg一种新型端粒酶激活剂

P. Raghavan
{"title":"《追求不朽》:介绍Metadicholandreg一种新型端粒酶激活剂","authors":"P. Raghavan","doi":"10.4172/2157-7633.1000446","DOIUrl":null,"url":null,"abstract":"Humans are keenly aware of their mortality. Given a limited time what we do with our life is a reflection of knowledge of our mortality. In 2009 the Nobel prize in medicine to Jack W Szostak, Elizabeth Blackburn, Carol W Greider for their work on Telomerase scientific research exploded in this area. Telomere and Telomerase protect chromosome ends the enzyme that maintains this. This activity of Telomerase is essential in cancer, aging and stem cells and achieving longer life spans. Telomerase is expressed in 85% of human cancer cell lines, but its enzymatic activity is not detectable in most human somatic cells which constitute the vast majority of the cells in the human body. There is a need for increased telomerase activity in stem cells for use in the treatment of therapies where there is an active role for telomerase. Umbilical Cord Blood (UCB) provides an attractive source of stem cells for research and therapeutic uses. Work present here characterizes the gene expression changes from Umbilical cord cells differentiate toward telomerase on treatment with Metadichol®. Metadichol® is a nanoemulsion of long-chain alcohols that is nontoxic. It is a mixture of long-chain alcohols derived from food. Since it expresses the Klotho gene which inhibits cancer cells it has fulfills the need for a safe telomerase inhibitor that reduces the risk of cancer. The work presented here is about the effect of Metadichol® on Telomerase expression profile in Umbilical cord cells. Our results using q-RT-PCR show increases of mRNA telomerase expression by Sixteen-fold at one picogram but down-regulates expression at higher concentrations of 100 pg, 1 ng, 100 ng and one microgram per ml concentration. Western blot studies showed expression of Telomerase protein which is slightly higher than control at one picogram, i.e., Telomerase protein expression continues at replacement level. This expression in vivo of mRNA is a new therapeutic pathway to mitigating diseases should be off of interest to researchers that is tantamount to making our bodies a drug factory. Since it is devoid of toxic effects, it can be directly tested on humans and is in use today as an immune boosting supplement. Metadichol® increases expression of Klotho an anti-aging gene expression in cancer cell lines by Four to Ten-fold, and Klotho gene has been documented to inhibits the growth of cancer cells. Metadichol® also inhibits TNF, ICAM1, CCL2, and BCAT1 which that is associated with proliferation in yeast and increased metastatic potential in human cancers. It paves the way for safe clinical testing and research and study of Telomerase biology and its use in humans.","PeriodicalId":89694,"journal":{"name":"Journal of stem cell research & therapy","volume":"9 1","pages":"1-7"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Quest for Immortality: Introducing Metadicholandreg; a Novel Telomerase Activator\",\"authors\":\"P. Raghavan\",\"doi\":\"10.4172/2157-7633.1000446\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Humans are keenly aware of their mortality. Given a limited time what we do with our life is a reflection of knowledge of our mortality. In 2009 the Nobel prize in medicine to Jack W Szostak, Elizabeth Blackburn, Carol W Greider for their work on Telomerase scientific research exploded in this area. Telomere and Telomerase protect chromosome ends the enzyme that maintains this. This activity of Telomerase is essential in cancer, aging and stem cells and achieving longer life spans. Telomerase is expressed in 85% of human cancer cell lines, but its enzymatic activity is not detectable in most human somatic cells which constitute the vast majority of the cells in the human body. There is a need for increased telomerase activity in stem cells for use in the treatment of therapies where there is an active role for telomerase. Umbilical Cord Blood (UCB) provides an attractive source of stem cells for research and therapeutic uses. Work present here characterizes the gene expression changes from Umbilical cord cells differentiate toward telomerase on treatment with Metadichol®. Metadichol® is a nanoemulsion of long-chain alcohols that is nontoxic. It is a mixture of long-chain alcohols derived from food. Since it expresses the Klotho gene which inhibits cancer cells it has fulfills the need for a safe telomerase inhibitor that reduces the risk of cancer. The work presented here is about the effect of Metadichol® on Telomerase expression profile in Umbilical cord cells. Our results using q-RT-PCR show increases of mRNA telomerase expression by Sixteen-fold at one picogram but down-regulates expression at higher concentrations of 100 pg, 1 ng, 100 ng and one microgram per ml concentration. Western blot studies showed expression of Telomerase protein which is slightly higher than control at one picogram, i.e., Telomerase protein expression continues at replacement level. This expression in vivo of mRNA is a new therapeutic pathway to mitigating diseases should be off of interest to researchers that is tantamount to making our bodies a drug factory. Since it is devoid of toxic effects, it can be directly tested on humans and is in use today as an immune boosting supplement. Metadichol® increases expression of Klotho an anti-aging gene expression in cancer cell lines by Four to Ten-fold, and Klotho gene has been documented to inhibits the growth of cancer cells. Metadichol® also inhibits TNF, ICAM1, CCL2, and BCAT1 which that is associated with proliferation in yeast and increased metastatic potential in human cancers. It paves the way for safe clinical testing and research and study of Telomerase biology and its use in humans.\",\"PeriodicalId\":89694,\"journal\":{\"name\":\"Journal of stem cell research & therapy\",\"volume\":\"9 1\",\"pages\":\"1-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of stem cell research & therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2157-7633.1000446\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of stem cell research & therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2157-7633.1000446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

人类敏锐地意识到他们的死亡。在有限的时间里,我们在生活中所做的事情反映了我们对死亡的认识。2009年,诺贝尔医学奖颁给了Jack W .绍斯塔克、Elizabeth Blackburn和Carol W . Greider,以表彰他们对端粒酶的研究。端粒和端粒酶保护染色体末端这是维持染色体末端的酶。端粒酶的这种活性对癌症、衰老和干细胞以及延长寿命至关重要。端粒酶在85%的人类癌细胞系中表达,但在大多数人体体细胞中检测不到其酶活性,而人体细胞占绝大多数。有必要增加端粒酶在干细胞中的活性,以用于端粒酶有活性作用的治疗。脐带血(UCB)为研究和治疗用途提供了有吸引力的干细胞来源。本研究描述了Metadichol®治疗后脐带细胞向端粒酶分化的基因表达变化。Metadichol®是一种无毒的长链醇纳米乳液。它是一种从食物中提取的长链醇的混合物。由于它表达了抑制癌细胞的Klotho基因,因此它满足了对安全的端粒酶抑制剂的需求,从而降低了患癌症的风险。本文介绍的工作是关于Metadichol®对脐带细胞端粒酶表达谱的影响。我们使用q-RT-PCR的结果显示,mRNA端粒酶的表达在1 picgram时增加了16倍,但在100 pg, 1 ng, 100 ng和1微克/ ml浓度的较高浓度下表达下调。Western blot研究显示,端粒酶蛋白的表达在一个图上略高于对照组,即端粒酶蛋白的表达继续处于替代水平。这种mRNA在体内的表达是一种新的治疗途径,可以减轻疾病,这应该引起研究人员的兴趣,这无异于让我们的身体成为一个药物工厂。由于它没有毒性作用,它可以直接在人体上进行测试,并且今天被用作免疫增强补充剂。Metadichol®可使抗衰老基因Klotho在癌细胞中的表达增加4至10倍,并且Klotho基因已被证明可抑制癌细胞的生长。Metadichol®还抑制TNF, ICAM1, CCL2和BCAT1,这些与酵母增殖和人类癌症转移潜力增加有关。它为端粒酶生物学及其在人类中的应用的安全临床试验和研究铺平了道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Quest for Immortality: Introducing Metadicholandreg; a Novel Telomerase Activator
Humans are keenly aware of their mortality. Given a limited time what we do with our life is a reflection of knowledge of our mortality. In 2009 the Nobel prize in medicine to Jack W Szostak, Elizabeth Blackburn, Carol W Greider for their work on Telomerase scientific research exploded in this area. Telomere and Telomerase protect chromosome ends the enzyme that maintains this. This activity of Telomerase is essential in cancer, aging and stem cells and achieving longer life spans. Telomerase is expressed in 85% of human cancer cell lines, but its enzymatic activity is not detectable in most human somatic cells which constitute the vast majority of the cells in the human body. There is a need for increased telomerase activity in stem cells for use in the treatment of therapies where there is an active role for telomerase. Umbilical Cord Blood (UCB) provides an attractive source of stem cells for research and therapeutic uses. Work present here characterizes the gene expression changes from Umbilical cord cells differentiate toward telomerase on treatment with Metadichol®. Metadichol® is a nanoemulsion of long-chain alcohols that is nontoxic. It is a mixture of long-chain alcohols derived from food. Since it expresses the Klotho gene which inhibits cancer cells it has fulfills the need for a safe telomerase inhibitor that reduces the risk of cancer. The work presented here is about the effect of Metadichol® on Telomerase expression profile in Umbilical cord cells. Our results using q-RT-PCR show increases of mRNA telomerase expression by Sixteen-fold at one picogram but down-regulates expression at higher concentrations of 100 pg, 1 ng, 100 ng and one microgram per ml concentration. Western blot studies showed expression of Telomerase protein which is slightly higher than control at one picogram, i.e., Telomerase protein expression continues at replacement level. This expression in vivo of mRNA is a new therapeutic pathway to mitigating diseases should be off of interest to researchers that is tantamount to making our bodies a drug factory. Since it is devoid of toxic effects, it can be directly tested on humans and is in use today as an immune boosting supplement. Metadichol® increases expression of Klotho an anti-aging gene expression in cancer cell lines by Four to Ten-fold, and Klotho gene has been documented to inhibits the growth of cancer cells. Metadichol® also inhibits TNF, ICAM1, CCL2, and BCAT1 which that is associated with proliferation in yeast and increased metastatic potential in human cancers. It paves the way for safe clinical testing and research and study of Telomerase biology and its use in humans.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信